Omnicell (OMCL) Accumulated Expenses (2010 - 2026)
Omnicell's (OMCL) quarterly Accumulated Expenses came in at $148.5 million in Q2 2026, down 2.22% year-over-year from $151.9 million in Q2 2025, and down 10.76% quarter-over-quarter from $166.4 million in Q1 2026.
Analysis
Omnicell (OMCL) Accumulated Expenses (2010 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Accumulated Expenses for 17 consecutive years, with $148.5 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Accumulated Expenses fell 2.22% year-over-year to $148.5 million in Q2 2026; TTM through Jun 2026 was $148.5 million, a 2.22% decrease from a year earlier, with the FY2025 full-year figure at $203.6 million, up 21.26% from the prior year.
- Accumulated Expenses was $148.5 million for Q2 2026 at Omnicell, down from $166.4 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $203.6 million in Q4 2025 and troughed at $136.5 million in Q2 2022.
- A 5-year average of $160.4 million and a median of $155.0 million in 2024 frame the typical range for Accumulated Expenses.
- Across the five-year window, Accumulated Expenses surged 66.31% in 2022 and slipped 15.98% in 2024, its largest moves.
- Over 5 years, Accumulated Expenses stood at $172.7 million in 2022, then retreated by 13.54% to $149.3 million in 2023, then rose by 12.47% to $167.9 million in 2024, then gained by 21.26% to $203.6 million in 2025, then retreated by 27.06% to $148.5 million in 2026.
- The last three Accumulated Expenses figures came in at $148.5 million (Q2 2026), $166.4 million (Q1 2026), and $203.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 148.50 Mn |
| Mar 31, 2026 | 166.41 Mn |
| Dec 31, 2025 | 203.59 Mn |
| Sep 30, 2025 | 165.34 Mn |
| Jun 30, 2025 | 151.88 Mn |
| Mar 31, 2025 | 173.63 Mn |
| Dec 31, 2024 | 167.90 Mn |
| Sep 30, 2024 | 144.25 Mn |
| Jun 30, 2024 | 158.12 Mn |
| Mar 31, 2024 | 167.19 Mn |
| Dec 31, 2023 | 149.28 Mn |
| Sep 30, 2023 | 150.39 Mn |
| Jun 30, 2023 | 145.89 Mn |
| Mar 31, 2023 | 198.98 Mn |
| Dec 31, 2022 | 172.66 Mn |
| Sep 30, 2022 | 146.44 Mn |
| Jun 30, 2022 | 136.52 Mn |
| Mar 31, 2022 | 139.83 Mn |
| Dec 31, 2021 | 133.17 Mn |
| Sep 30, 2021 | 104.24 Mn |